Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022

Descripción del Articulo

Background. Tuberculosis is a public health problem considered to be the world's leading cause of death from an infectious disease among adults. Diagnosis is often challenging and is based on clinical, epidemiological, radiological, bacteriological, histological and biochemical findings. Timely...

Descripción completa

Detalles Bibliográficos
Autores: Mosqueira Sanchez, Jorge Roberto, Paredes Moreno, María Angélica, Layseca Ortiz, Julio César, Mogrovejo Olivera, Nancy Victoria, Oyarce Calderón, Alvaro
Formato: artículo
Fecha de Publicación:2023
Institución:Universidad Ricardo Palma
Repositorio:Revistas - Universidad Ricardo Palma
Lenguaje:español
inglés
OAI Identifier:oai:oai.revistas.urp.edu.pe:article/5815
Enlace del recurso:http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815
Nivel de acceso:acceso abierto
Materia:Tuberculosis
Mycobacterium tuberculosis
Drug Resistance
Infections
Farmacorresistencia
Infecciones
id REVURP_110fed3c383110ffac5455773040f4e0
oai_identifier_str oai:oai.revistas.urp.edu.pe:article/5815
network_acronym_str REVURP
network_name_str Revistas - Universidad Ricardo Palma
repository_id_str
dc.title.none.fl_str_mv Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022: Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022
title Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
spellingShingle Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
Mosqueira Sanchez, Jorge Roberto
Tuberculosis
Mycobacterium tuberculosis
Drug Resistance
Infections
Tuberculosis
Mycobacterium tuberculosis
Farmacorresistencia
Infecciones
title_short Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
title_full Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
title_fullStr Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
title_full_unstemmed Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
title_sort Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022
dc.creator.none.fl_str_mv Mosqueira Sanchez, Jorge Roberto
Paredes Moreno, María Angélica
Layseca Ortiz, Julio César
Mogrovejo Olivera, Nancy Victoria
Oyarce Calderón, Alvaro
author Mosqueira Sanchez, Jorge Roberto
author_facet Mosqueira Sanchez, Jorge Roberto
Paredes Moreno, María Angélica
Layseca Ortiz, Julio César
Mogrovejo Olivera, Nancy Victoria
Oyarce Calderón, Alvaro
author_role author
author2 Paredes Moreno, María Angélica
Layseca Ortiz, Julio César
Mogrovejo Olivera, Nancy Victoria
Oyarce Calderón, Alvaro
author2_role author
author
author
author
dc.subject.none.fl_str_mv Tuberculosis
Mycobacterium tuberculosis
Drug Resistance
Infections
Tuberculosis
Mycobacterium tuberculosis
Farmacorresistencia
Infecciones
topic Tuberculosis
Mycobacterium tuberculosis
Drug Resistance
Infections
Tuberculosis
Mycobacterium tuberculosis
Farmacorresistencia
Infecciones
description Background. Tuberculosis is a public health problem considered to be the world's leading cause of death from an infectious disease among adults. Diagnosis is often challenging and is based on clinical, epidemiological, radiological, bacteriological, histological and biochemical findings. Timely diagnosis, identification of the susceptibility profile and follow-up compliance is important to enable more effective treatment and avoid severe forms of the disease. Aim. Describe the resistance patterns of Mycobacterium tuberculosis identified in the period of the year 2022 at Hospital María Auxiliadora. Material and Methods. This is an observational, cross-sectional study of patients diagnosed with tuberculosis throughout the year 2022 in the Tuberculosis Center of Excellence (TB COE), division of the respiratory medicine department at the Hospital Maria Auxiliadora, Lima, Peru. Data was collected from the medical records which was then included for the statistical analysis. The clinical and demographic characteristics were described by absolute frequencies and percentages. Chi-square test and Fisher's exact test were used to evaluate the association between the sensitivity profile of tuberculosis and the independent variables. A p-value < 0.05 was considered as statistically significant. Results. A total of 261 medical records were included in the present study. The most frequent age group was 17-59 years old, the majority were male (62.1%) and 15.7% were relapses, as established on national technical standard. Of the total, 89.7% were sensitive to first line drugs; 6.1% of the patients were multidrug-resistant (MDR), and 0.8% presented extensively drug-resistance (XDR); likewise, 0.8% and 2.7% presented resistance for rifampicin only and resistance for isoniazid only respectively. HIV infection was found at 14.2%. The most common form of tuberculosis was pulmonary (49%) followed by pleural tuberculosis (21.8%). Conclusion. Tuberculosis is a worldwide condition whose drug-resistance patterns continue evolving. However, in our hospital, a southern Peru reference Center, most TB patients are still sensitive to first line drugs. Only a small amount of MDR and XDR patients were found. Moreover, the most common clinical presentation was pulmonary followed by pleural tuberculosis.
publishDate 2023
dc.date.none.fl_str_mv 2023-12-06
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815
10.25176/RFMH.v23i3.5815
url http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815
identifier_str_mv 10.25176/RFMH.v23i3.5815
dc.language.none.fl_str_mv spa
eng
language spa
eng
dc.relation.none.fl_str_mv http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9451
http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9450
http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9452
http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9453
dc.rights.none.fl_str_mv Derechos de autor 2023 Revista de la Facultad de Medicina Humana
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Derechos de autor 2023 Revista de la Facultad de Medicina Humana
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
text/html
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Universidad Ricardo Palma
publisher.none.fl_str_mv Universidad Ricardo Palma
dc.source.none.fl_str_mv Revista de la Facultad de Medicina Humana; Vol. 23 No. 3 (2023): Revista de la Facultad de Medicina Humana; 79 - 91
Revista de la Facultad de Medicina Humana; Vol. 23 Núm. 3 (2023): Revista de la Facultad de Medicina Humana; 79 - 91
2308-0531
1814-5469
reponame:Revistas - Universidad Ricardo Palma
instname:Universidad Ricardo Palma
instacron:URP
instname_str Universidad Ricardo Palma
instacron_str URP
institution URP
reponame_str Revistas - Universidad Ricardo Palma
collection Revistas - Universidad Ricardo Palma
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1789625150254088192
spelling Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022: Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022Evaluación de los patrones de farmacorresistencia de Mycobacterium Tuberculosis en un hospital público de Lima, Perú durante 2022: Assessment of Mycobacterium Tuberculosis drug-resistance patterns in a public hospital of Lima, Peru during 2022Mosqueira Sanchez, Jorge RobertoParedes Moreno, María Angélica Layseca Ortiz, Julio César Mogrovejo Olivera, Nancy Victoria Oyarce Calderón, Alvaro TuberculosisMycobacterium tuberculosisDrug ResistanceInfectionsTuberculosisMycobacterium tuberculosisFarmacorresistenciaInfeccionesBackground. Tuberculosis is a public health problem considered to be the world's leading cause of death from an infectious disease among adults. Diagnosis is often challenging and is based on clinical, epidemiological, radiological, bacteriological, histological and biochemical findings. Timely diagnosis, identification of the susceptibility profile and follow-up compliance is important to enable more effective treatment and avoid severe forms of the disease. Aim. Describe the resistance patterns of Mycobacterium tuberculosis identified in the period of the year 2022 at Hospital María Auxiliadora. Material and Methods. This is an observational, cross-sectional study of patients diagnosed with tuberculosis throughout the year 2022 in the Tuberculosis Center of Excellence (TB COE), division of the respiratory medicine department at the Hospital Maria Auxiliadora, Lima, Peru. Data was collected from the medical records which was then included for the statistical analysis. The clinical and demographic characteristics were described by absolute frequencies and percentages. Chi-square test and Fisher's exact test were used to evaluate the association between the sensitivity profile of tuberculosis and the independent variables. A p-value < 0.05 was considered as statistically significant. Results. A total of 261 medical records were included in the present study. The most frequent age group was 17-59 years old, the majority were male (62.1%) and 15.7% were relapses, as established on national technical standard. Of the total, 89.7% were sensitive to first line drugs; 6.1% of the patients were multidrug-resistant (MDR), and 0.8% presented extensively drug-resistance (XDR); likewise, 0.8% and 2.7% presented resistance for rifampicin only and resistance for isoniazid only respectively. HIV infection was found at 14.2%. The most common form of tuberculosis was pulmonary (49%) followed by pleural tuberculosis (21.8%). Conclusion. Tuberculosis is a worldwide condition whose drug-resistance patterns continue evolving. However, in our hospital, a southern Peru reference Center, most TB patients are still sensitive to first line drugs. Only a small amount of MDR and XDR patients were found. Moreover, the most common clinical presentation was pulmonary followed by pleural tuberculosis.Antecedentes. La tuberculosis es un problema de salud pública considerado la principal causa mundial de muerte por una enfermedad infecciosa entre los adultos. El diagnóstico suele ser difícil y se basa en hallazgos clínicos, epidemiológicos, radiológicos, bacteriológicos, histológicos y bioquímicos. El diagnóstico oportuno, la identificación del perfil de susceptibilidad y el cumplimiento del seguimiento son importantes para permitir un tratamiento más eficaz y evitar formas graves de la enfermedad. Objetivo. Describir los patrones de resistencia de Mycobacterium tuberculosis identificados en el periodo del año 2022 en el Hospital María Auxiliadora. Material y métodos. Se trata de un estudio observacional, transversal, de pacientes diagnosticados de tuberculosis durante todo el año 2022 en el Centro de Excelencia en Tuberculosis (COE-TB), división del servicio de medicina respiratoria del Hospital María Auxiliadora, Lima, Perú. Los datos fueron recolectados de las historias clínicas que luego fueron incluidas para el análisis estadístico. Las características clínicas y demográficas se describieron mediante frecuencias absolutas y porcentajes. Para evaluar la asociación entre el perfil de sensibilidad de la tuberculosis y las variables independientes se utilizó la prueba de Chi cuadrado y la prueba exacta de Fisher. Un valor p < 0,05 se consideró estadísticamente significativo. Resultados. Se incluyeron en el presente estudio 261 historias clínicas. El grupo de edad más frecuente fue el de 17-59 años, la mayoría eran varones (62,1%) y el 15,7% eran recidivantes, según lo establecido en la norma técnica nacional. Del total, el 89,7% eran sensibles a fármacos de primera línea; el 6,1% de los pacientes eran multirresistentes (MDR), y el 0,8% presentaban resistencia extensiva a fármacos (XDR); asimismo, el 0,8% y el 2,7% presentaban resistencia sólo para rifampicina y resistencia sólo para isoniazida respectivamente. La infección por VIH se detectó en el 14,2%. La forma más frecuente de tuberculosis fue la pulmonar (49%), seguida de la tuberculosis pleural (21,8%). Conclusiones. La tuberculosis es una afección mundial cuyos patrones de farmacorresistencia continúan evolucionando. Sin embargo, en nuestro hospital, un centro de referencia del sur del Perú, la mayoría de los pacientes con TB siguen siendo sensibles a los fármacos de primera línea. Sólo se encontró una pequeña cantidad de pacientes MDR y XDR. Además, la presentación clínica más frecuente fue la tuberculosis pulmonar seguida de la pleural.Universidad Ricardo Palma2023-12-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmltext/htmlapplication/pdfapplication/pdfhttp://revistas.urp.edu.pe/index.php/RFMH/article/view/581510.25176/RFMH.v23i3.5815Revista de la Facultad de Medicina Humana; Vol. 23 No. 3 (2023): Revista de la Facultad de Medicina Humana; 79 - 91Revista de la Facultad de Medicina Humana; Vol. 23 Núm. 3 (2023): Revista de la Facultad de Medicina Humana; 79 - 912308-05311814-5469reponame:Revistas - Universidad Ricardo Palmainstname:Universidad Ricardo Palmainstacron:URPspaenghttp://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9451http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9450http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9452http://revistas.urp.edu.pe/index.php/RFMH/article/view/5815/9453Derechos de autor 2023 Revista de la Facultad de Medicina Humanahttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:oai.revistas.urp.edu.pe:article/58152023-12-21T19:05:18Z
score 13.983407
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).